Cancer BiologyCellular and Molecular Gastroenterology and HepatologyPeer-reviewed
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma
Emilien J. Loeuillard, Binbin Li, Hannah E. Stumpf…·Sumera Irie Ilyas
This study shows that TRAIL+ cancer cells use noncanonical TRAIL signaling in MDSCs to promote their abundance and tumor progression in cholangiocarcinoma.